GSK Plc (GSK)
59.52
-1.33
(-2.19%)
USD |
NYSE |
Feb 20, 16:00
59.53
+0.01
(+0.02%)
After-Hours: 20:00
GSK EPS Diluted (Quarterly) : 0.414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.743 |
| Mereo BioPharma Group Plc | -0.0436 |
| Novavax, Inc. | -1.246 |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 0.5208 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 966.83M |
| Revenue (Quarterly) | 11.46B |
| Total Expenses (Quarterly) | 10.62B |
| Enterprise Value | 138.12B |
| Gross Profit Margin (Quarterly) | 69.38% |
| Profit Margin (Quarterly) | 8.44% |
| Earnings Yield | 6.16% |
| Operating Earnings Yield | 7.96% |
| Normalized Earnings Yield | 6.645 |